Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$533M |
| 2 |
Apple
AAPL
|
+$347M |
| 3 |
Micron Technology
MU
|
+$272M |
| 4 |
Eli Lilly
LLY
|
+$232M |
| 5 |
Super Micro Computer
SMCI
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$472M |
| 2 |
NVIDIA
NVDA
|
+$413M |
| 3 |
Tesla
TSLA
|
+$403M |
| 4 |
Coinbase
COIN
|
+$236M |
| 5 |
Johnson & Johnson
JNJ
|
+$224M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.66% |
| 2 | Healthcare | 16.81% |
| 3 | Consumer Discretionary | 13.04% |
| 4 | Industrials | 9.63% |
| 5 | Financials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
PDS Biotechnology
PDSB
$39.5M
| $88.6K | ﹤0.01% |
+23,200
| New | +$77.4K |
|
3277
Dominari Holdings
DOMH
$56.1M
| $86.8K | ﹤0.01% |
46,926
+1,000
| +2% | +$1.78K |
|
|
CHRN
3278
ChronoScale Holdings
CHRN
$3.5B
| $86.6K | ﹤0.01% |
4,974
-60
| -1% | -$1.02K |
|
3279
TTEC Holdings
TTEC
$125M
| $86.4K | ﹤0.01% |
+14,722
| New | +$80.3K |
|
|
SUPX
3280
SuperX AI Technology Ltd
SUPX
$310M
| $85.6K | ﹤0.01% |
+18,700
| New | +$88.2K |
|
3281
Southland Holdings
SLND
$34.2M
| $85.5K | ﹤0.01% |
23,100
-9,100
| -28% | -$35.5K |
|
3282
Generation Income Properties
GIPR
$726K
| $84.9K | ﹤0.01% |
3,877
+1,017
| +36% | +$27.4K |
|
3283
Relmada Therapeutics
RLMD
$566M
| $83.9K | ﹤0.01% |
25,888
-62,887
| -71% | -$204K |
|
|
WHLM
3284
DELISTED
Wilhelmina International, Inc
WHLM
| $83.8K | ﹤0.01% |
20,100
-300
| -1% | -$1.59K |
|
3285
Urban One Class A
UONE
$23.7M
| $83.6K | ﹤0.01% |
4,750
-670
| -12% | -$13.3K |
|
|
TMQ
3286
Trilogy Metals
TMQ
$608M
| $82.8K | ﹤0.01% |
171,000
+78,300
| +84% | +$43.4K |
|
|
MSC
3287
Studio City International Holdings
MSC
$362M
| $80.9K | ﹤0.01% |
10,785
-100
| -0.9% | -$635 |
|
3288
ARKO Corp
ARKO
$850M
| $80.7K | ﹤0.01% |
11,500
-69,700
| -86% | -$440K |
|
3289
MiNK Therapeutics
INKT
$54.8M
| $80K | ﹤0.01% |
10,669
-2,115
| -17% | -$17.9K |
|
3290
SOPHiA GENETICS
SOPH
$544M
| $79.9K | ﹤0.01% |
21,900
-100
| -0.5% | -$406 |
|
|
HERE
3291
Here Group Ltd
HERE
$103M
| $79.8K | ﹤0.01% |
34,400
+4,900
| +17% | +$8.45K |
|
|
XELA
3292
DELISTED
Exela Technologies, Inc. Common Stock
XELA
| $79.7K | ﹤0.01% |
38,700
+7,700
| +25% | +$16.9K |
|
3293
BioXcel Therapeutics
BTAI
$26.8M
| $79.2K | ﹤0.01% |
+8,117
| New | +$109K |
|
|
NBP
3294
NovaBridge Biosciences American Depositary Shares
NBP
$192M
| $79.1K | ﹤0.01% |
63,800
| – | – |
|
3295
Offerpad Solutions
OPAD
$22.4M
| $78.2K | ﹤0.01% |
1,925
+90
| +5% | +$3.62K |
|
3296
Prime Medicine
PRME
$553M
| $77.4K | ﹤0.01% |
+20,000
| New | +$92.6K |
|
|
RPT
3297
Rithm Property Trust
RPT
$93M
| $76.8K | ﹤0.01% |
3,841
-717
| -16% | -$14.9K |
|
3298
8x8 Inc
EGHT
$323M
| $74.9K | ﹤0.01% |
36,700
+21,400
| +140% | +$47.2K |
|
3299
INNOVATE Corp
VATE
$103M
| $73.6K | ﹤0.01% |
+19,879
| New | +$98.2K |
|
3300
Lulu's Fashion Lounge
LVLU
$52.1M
| $73.4K | ﹤0.01% |
3,060
+60
| +2% | +$1.34K |
|
Similar funds
Renaissance Technologies's Q3 2024 Portfolio in Review
As of Q3 2024, Renaissance Technologies held 4,024 positions worth $66.5B, up 13% from $59B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies deployed $3.2B of net new capital in Q3 2024, opening 578 new positions and adding to 1,558 existing holdings. Its largest new stake was Micron Technology: 2,604,914 shares worth $270M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $413M trimmed.
- Renaissance Technologies's largest Q3 2024 buy was Micron Technology: 2,604,914 shares worth $270M.
- Renaissance Technologies added most to Microsoft in Q3 2024, an estimated $533M increase.
- Renaissance Technologies's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $413M.
- Renaissance Technologies fully exited Broadcom in Q3 2024, selling an estimated $472M.
- Renaissance Technologies's ten largest holdings make up 11% of its $66.5B portfolio in Q3 2024.
- Renaissance Technologies opened 578 new positions and closed 539 in Q3 2024.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $66.5B.
Based on Renaissance Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.